VOR — Vor Biopharma Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-02-05.
Performance
Technicals
Others in Healthcare
Measured signals that fired on VOR
| date | signal | measured base rate |
|---|---|---|
| 2026-08-05 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-01 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-29 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-06-12 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-05-06 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-16 | Shah Rajeev M. 10% owner | Open-market sale | 213 | 19.75 | 4.2K |
| 2026-07-16 | Kolchinsky Peter 10% owner | Open-market sale | 213 | 19.75 | 4.2K |
| 2026-07-16 | RA Capital Healthcare Fund LP 10% owner | Open-market sale | 213 | 19.75 | 4.2K |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Open-market sale | 213 | 19.75 | 4.2K |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option Exercise | 2.1M | 0.00 | 4.2K |
| 2026-07-16 | Shah Rajeev M. 10% owner | Option Exercise | 2.1M | 0.00 | 4.2K |
| 2026-07-16 | RA Capital Healthcare Fund LP 10% owner | Option Exercise | 2.1M | 0.00 | 4.2K |
| 2026-07-16 | Kolchinsky Peter 10% owner | Option Exercise | 2.1M | 0.00 | 4.2K |
| 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. Director | Open-market sale | 165.2K | 15.77 | 2.6M |
| 2026-04-22 | RA Capital Healthcare Fund LP Director | Open-market sale | 165.2K | 15.77 | 2.6M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| TCG Crossover Management, LLC | 96.5M | 5.7M |
| RA CAPITAL MANAGEMENT, L.P. | 96.4M | 5.4M |
| FCPM III SERVICES B.V. | 73.5M | 4.1M |
| Venrock Adviser, LLC | 54.3M | 3.0M |
| Frazier Life Sciences Management, L.P. | 45.4M | 2.5M |
| Caligan Partners LP | 34.3M | 1.9M |
| Paradigm Biocapital Advisors LP | 31.2M | 1.8M |
| GREAT POINT PARTNERS LLC | 31.2M | 1.8M |
| FMR LLC | 27.5M | 1.5M |
| VANGUARD CAPITAL MANAGEMENT LLC | 25.6M | 1.4M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| 10-Q | 2026-08-11 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-07 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-06 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-07-30 | — | on EDGAR ↗ |
| SCHEDULE 13D/A | 2026-07-21 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Vor Biopharma reports Q2 results · 2026-08-12
Ask the AI about VOR
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →